Endocytosis and recycling control the uptake and retrieval of various materials in eukaryotic cells. Mammalian cells have ...

Following an investigational new drug application clearance from the FDA, a phase 1 trial plans to evaluate CD-001.

The significant rise in the use of biopharmaceutical and large molecule therapeutics over recent years has made peptides and proteins popular drug discovery targets for the pharmaceutical and ...

Biopharma has received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application of CD-001, entering a Phase I first-in-human ...

A study led by the Department of Energy's Oak Ridge National Laboratory details how artificial intelligence researchers have ...

TX45 was well-tolerated with no observed immunogenicity, and demonstrated a favorable PK/PD relationship which was used to identify doses for the ...

Innovent Biologics has made the case that its checkpoint inhibitor-cytokine fusion protein has a future in colorectal cancer.

IBI363 has earned fast track designation from the FDA for the treatment of previously treated unresectable advanced melanoma.

Thankfully, healthy snacking is possible. For example, choosing a high-protein snack between breakfast and lunch or before dinner can help keep you full and satisfied. Although everyone's daily ...

As a First in-class PD-1/IL-2α-bias bispecific antibody fusion protein, IBI363 monotherapy has shown encouraging efficacy and a favorable safety profile in melanoma subjects who have previously ...